Roche Venture Fund Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
176
- Portfolio
-
22
- Exits
-
111
Roche Venture Fund General Information
Company Description
Founded in 2002, Roche Venture Fund is a corporate venture capital arm of Roche, based in Basel, Switzerland. The firm prefers to invest in life science, fintech, digital health, pharmaceuticals and diagnostics sectors.
Business Details
Website
venturefund.roche.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- Grenzacherstrasse 124
- 4070 Basel
- Switzerland
Roche Venture Fund Investments (176)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Mironid | 05-Aug-2026 | Later Stage VC | Therapeutic Devices | Generating Revenue | ||
| Cour | 18-Jun-2026 | Drug Discovery | Clinical Trials - Phase 2 | |||
| EpiBiologics | 31-Oct-2025 | Drug Discovery | Generating Revenue | |||
| Mission Therapeutics | 15-Oct-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Receptive Bio | 01-Jul-2025 | Drug Delivery | Startup | |||
| SpliceBio | 19-May-2025 | Drug Discovery | Generating Revenue | |||
| Merge Therapeutics | 01-Jan-2025 | Drug Discovery | Startup | |||
| Forcefield Therapeutics | 28-Mar-2024 | Drug Discovery | Generating Revenue | |||
| Mission Therapeutics | 11-Mar-2024 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 2 | ||
| Freenome | 15-Feb-2024 | Later Stage VC | Biotechnology | Generating Revenue |
Roche Venture Fund Exits (111)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Silence Therapeutics | 11-Aug-2026 | Public Investment 2nd Offering | |
| Freenome | 20-Jul-2026 | ||
| CiVi Biopharma | 01-May-2026 | ||
| Vivet Therapeutics | 01-Mar-2026 | ||
| Soteria Biotherapeutics | 06-Jun-2025 | ||
| Fabric Genomics | 05-May-2025 | ||
| Nimble Therapeutics | 23-Jan-2025 | ||
| Syapse | 20-Dec-2024 | ||
| Arch Oncology | 31-May-2024 | Out of Business | |
| Enliven Therapeutics | 23-Feb-2023 | Reverse Merger |
Roche Venture Fund Investments by Industry, Year, and Region
Roche Venture Fund Co-Investors (79)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Sofinnova Partners | 3 |
|
|
||
| Bristol-Myers Squibb |
|
|
|||
| Novartis Venture Fund |
|
|
|||
| Polaris Partners |
|
|
|||
| Vivo Capital |
|
|
Roche Venture Fund FAQs
-
What is Roche Venture Fund?
Founded in 2002, Roche Venture Fund is a corporate venture capital arm of Roche, based in Basel, Switzerland.
-
When was Roche Venture Fund founded?
Roche Venture Fund was founded in 2002.
-
Where is Roche Venture Fund headquartered?
Roche Venture Fund is headquartered in Basel, Switzerland.
-
What is Roche Venture Fund's total asset value?
Roche Venture Fund has around in total assets under management.
-
How many investments has Roche Venture Fund made?
Roche Venture Fund has made 176 investments.
-
What has Roche Venture Fund invested in?
Roche Venture Fund has made numerous investments in companies like Mironid, Cour, and EpiBiologics within the Therapeutic Devices and Drug Discovery industries.
-
What has Roche Venture Fund invested in recently?
Roche Venture Fund's latest investment was on 05-Aug-2026 in Mironid, a company within the Therapeutic Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process